qualitative research grounded in SEC filings & market-flow signals Quant side · QuantOrb.pro ↗

CLX — Tear Sheet

CLOROX CO /DE/

covers US session 2026-11-03 · Tear sheet created 10 days ago

AdCho Opinion

Underweight

Bottom Line

Underweight: the beat is real but base-effect flattered and margins are eroding into management's own inflation warning, while overbought money flow and one-sided retail euphoria argue against pressing the short side — trim into strength, not exit

CLX daily chart

sessions

Loading chart…

How to read this chart
  1. Top: price candles (green up, red down) with Bollinger Bands (20, 2) in dashed orange, the 50-session average in blue, the 200-session average in dashed orange, and volume bars along the bottom
  2. Middle: RSI (14), Wilder’s method, with dashed guides at 30 and 70
  3. Bottom: MACD (12, 26, 9): MACD line, dashed signal line and a green/red histogram

Prices: Yahoo Finance daily bars, split- and dividend-adjusted; indicators computed on two years of history, then the window is cut · as of latest session · Chart by TradingView Lightweight Charts™ © TradingView, Inc.

Share this tear sheet

X Facebook LinkedIn Reddit WhatsApp Email

Executive Summary

  • We read the balance as Underweight: the bear desk won the substance, the bull desk won only momentum
  • The constructive leg is real — adjusted earnings well above expectations, cash flow up sharply, and a live money-flow continuation signal
  • The counterweight is margin erosion into management's own inflation warning, with headline organic growth flattered by lapping a prior-year inventory drawdown
  • The tape is stretched: overbought money flow, a close above the upper Bollinger band, and RSI near the fade zone
  • Location is poor: price sits under a falling long-term moving average with an unfilled gap overhead and rally volume well short of supply
  • Why not a full exit: the dividend floors the downside, and the stance is a tranched trim with defined re-entry triggers
  • The balance rests on the early-February print: margin stabilization evidence versus a reversing base effect, with mid-November inflation the first checkpoint

Market Sentiment

  • We read the verdict as mildly bullish — six-point-two out of ten — at low confidence, and we keep that restraint
  • The bullishness is one-sided and event-driven: seven labeled bulls against zero bears on a single social lane, the rest unlabeled
  • Coverage is thin: the X and Reddit lanes returned nothing, the company-news lane failed outright, and spam filtering never engaged
  • The global feed surfaced only unrelated technology headlines, so this window carries no captured CLX news on our sheet
  • CLX items on a margin-outlook cut and a leadership change circulated only as user-pasted links we cannot independently verify
  • We weight the sentiment leg light: euphoria after a print is real but unverifiable against institutional tone, and the usual contrarian counterweight is missing
  • The same feed that celebrated the beat also circulated the margin-cut headline, so the bullish label is less clean than it looks

News

No in-window news items for this session.

Social

No in-window X posts for this session.

Polymarket

Will no Fed rate cuts happen in 2026?
Yes 97% ($9,400,283 volume, resolves 2027-01-01, 1-week +1.0pp)

Will 11 Fed rate cuts happen in 2026?
Yes 0% ($5,331,578 volume, resolves 2027-01-01)

Will 10 Fed rate cuts happen in 2026?
Yes 0% ($4,991,762 volume, resolves 2027-01-01)

Will 9 Fed rate cuts happen in 2026?
Yes 0% ($4,315,465 volume, resolves 2027-01-01)

Will 6 Fed rate cuts happen in 2026?
Yes 0% ($4,248,444 volume, resolves 2027-01-01, 1-week -0.1pp)

Will 12 or more Fed rate cuts happen in 2026?
Yes 0% ($4,180,455 volume, resolves 2027-01-01, 1-week +0.1pp)

Live odds at run time (UTC) — macro market context, not company-specific; the rates, recession and fiscal-deadline odds every equity reads against. Not signals to act on. Topic: “Fed rate cut”.

Management Sentiment & Catalyst Highlights

  • Management's tone is mixed in the CEO's own words: better-than-expected results through strong execution and timing benefits, but a more challenging cost environment
  • The chief executive flagged higher inflationary pressures in the updated outlook while pointing to mitigation plans and continued brand investment
  • Guidance moved two ways: a full-year profit range whose midpoint sits above prior expectations, against an outlook that lowers the margin bar
  • The GOJO purchase reshapes the story: about fifteen points of the sales gain is consolidation, bought with a stretched balance sheet
  • Integration is the strategic pitch — management points to market-share gains and unlocking Purell ProCare potential as the medium-term engine
  • Visible catalysts: the mid-November inflation reading and the early-February second-quarter print, where the cost trajectory gets tested

Key Risk Factors

  • The primary risk is margin erosion: the weakest ex-cyberattack gross margin in years, confirmed by management's own inflation language
  • Growth quality is the second leg: organic gains lap a prior-year inventory drawdown and the base effect flips next quarter
  • Rates press a bond proxy: a hiking Fed and re-accelerating inflation strip the dividend of nearly all carry over the risk-free rate
  • GOJO left the balance sheet stretched — expanded liabilities, thin liquidity, and most of the purchase price in goodwill and intangibles
  • The tape cuts both ways: stretched money flow and a band-piercing close, against squeeze fuel from fresh moving-average crosses and euphoric retail flow
  • Evidence quality caps conviction: institutional positioning is months stale, the succession story never reconciled, and news signals rest on single pasted links
  • Counterweight: the adjusted beat and cash-flow surge are genuine, so the stance is a trim with triggers, not a fight with the tape

QuantOrb.pro Quantitative Signals

MFI (14-day)

78.45

accumulation zone · CONTINUATION screen

qOp signal strength

CONTINUATION · 75%

quantitative screen, not a recommendation

Organic growth

18%

Diluted EPS

$1.55

Adjusted EPS

$1.55

Money-flow and momentum readings from this run's own engine outputs (QuantOrb snapshot as cited in Sources; technicals as of the covered session) — context, not signals to act on.

Not a recommendation. A quantitative screen, not a recommendation — the 13F data are a non-exhaustive quarter-end snapshot subject to a reporting lag of up to 45 days.

qOp quant view →

Sources

Facts (verifiable): SEC filings via the QuantOrb document corpus · QuantOrb money-flow & 13F datasets. Reading (AI-powered): AdCho’s synthesis via a multi-analyst AI engine.

Sheet schema adcho.tearsheet.v1 · rendered by AdCho · freshness day 10 (D11 day-0 rule, US-session dates only)